Transpulmonary Pressure-Guided Ventilation Weaning for Obesity-Related Respiratory Issues
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores a new method to help obese patients on ventilators breathe better and be removed from the ventilator sooner. The study compares two ventilator settings: one uses a standard approach (standard positive end expiratory pressure), and the other adjusts based on a specific lung pressure measurement (transpulmonary pressure guided positive end expiratory pressure). The goal is to reduce ventilator time, thereby decreasing the risk of complications such as infections or weakness. Suitable participants are those who are severely obese (BMI of 35 or higher) and have been on a ventilator for less than 48 hours due to breathing issues.
As an unphased trial, this study provides a unique opportunity to contribute to innovative research that could enhance ventilator care for obese patients.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that this protocol is safe for patients with obesity-related respiratory issues?
Research shows that a specific method to guide breathing support safely aids obese patients. This method adjusts breathing machine settings to improve blood oxygen levels. It measures chest pressure in a minimally invasive and low-risk manner. This approach has succeeded in similar cases, making it a promising option for reducing the time patients need on breathing machines.12345
Why are researchers excited about this trial?
Researchers are excited about transpulmonary pressure-guided ventilation weaning for obesity-related respiratory issues because it offers a more personalized approach to setting ventilator pressures. Unlike the standard method where positive end expiratory pressure (PEEP) is set to a general range of 5-8 cm H2O, this technique adjusts PEEP based on each patient's transpulmonary pressure to a range of 0-2 cm H2O. This tailored method could potentially enhance the effectiveness of ventilation and improve outcomes by ensuring that the pressure settings are better suited to the individual's respiratory mechanics.
What evidence suggests that transpulmonary pressure guided positive end expiratory pressure is effective for obesity-related respiratory issues?
Research shows that adjusting breathing machine settings using a specific method can improve outcomes for obese patients. In this trial, one group of participants will receive transpulmonary pressure-guided positive end expiratory pressure (PEEP). This technique uses transpulmonary pressure to guide PEEP adjustments, a ventilator setting that helps keep the lungs open. Studies have found that this approach can safely improve blood oxygen levels by balancing lung pressure, making breathing easier and more effective. Better oxygen levels can lead to less time on the ventilator, reducing the risk of complications like infections or muscle weakness. This method appears promising for assisting obese patients with breathing problems.12346
Are You a Good Fit for This Trial?
This trial is for obese patients (BMI ≥ 35.0 kg/m²) who have been on a ventilator for less than 48 hours due to respiratory failure. It's not suitable for those with esophageal or gastrointestinal issues, low platelet counts, neuromuscular diseases, difficult airways, life expectancy under 48 hours, prior chronic ventilation needs, severe neurological injuries or known pleural diseases.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Transpulmonary pressure guided positive end expiratory pressure (PEEP) titration for ventilation and spontaneous breathing trials (SBT) to shorten the time to liberation from mechanical ventilation
Follow-up
Participants are monitored for safety and effectiveness after treatment, including mortality, ICU and hospital length of stay, and re-intubation rates
What Are the Treatments Tested in This Trial?
Interventions
- standard positive end expiratory pressure
- transpulmonary pressure guided positive end expiratory pressure
transpulmonary pressure guided positive end expiratory pressure is already approved in United States, European Union for the following indications:
- Mechanical ventilation management in obese patients
- ARDS management
- Mechanical ventilation optimization in obese patients
- ARDS treatment
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Mississippi Medical Center
Lead Sponsor